First Berlin Equity Research GmbH’s Post

Will public biotech equities continue to be subjected to the #volatility of interest #rates?   The Wall Street Journal pointed out that, in the first quarter of 2024, public biotechs had raised $5.7B using a structure called PIPEs, or “private investments in public companies.” The theme of the article was the perhaps unfair advantage of PIPE investors, who often have access to non-public information, including trial results. Upon the announcement of the investment, sometimes together with trial results, shares frequently experience a substantial rise.   Leaving value judgements aside, what it illuminates to me is the extreme undervaluation of publicly traded biotech equities, beaten down severely by high interest rates. This clearly presents financing competition to private biotech companies. But it also says that non-generalist, sophisticated institutional investors are willing to invest serious sums in public entities where they can do so without themselves goosing the stock price.   Is there an event on the horizon which might cause generalist investors to understand this undervaluation, or will public biotech equities continue to be subjected to the volatility of interest rates?   Comment below with your thoughts. Source: Wainer, David. (16 April, 2024). Wall Street Journal. Certain Biotech Investors Get an Early Look at Results. Is That Fair? Article in comments field.

Mein persönlicher Input zum Thema Innovation, heute von # : 2 Innovative Cathie Wood Stocks to Buy If You Can Stomach the Risk Info: Alle dargestellten Meinungen und Aussagen sind meine persönlichen und weder mit @JPM noch mit @MyMineralMix assoziiert.

🔍 Welche mittelfristigen Trends gibt es im Nebenwerte-Segment? Miguel Lago Mascato, Senior Equity Analyst, teilt seine spannenden Einblicke im Interview. Erfahrt mehr über die Zukunft dieser dynamischen Märkte! 🧠✨ #ResearchExcellence #MontegaAG #FinanceInsights #MontegaShorts #Investmentbanking #aktien #nebenwerte #assetmanagement #investorrelations #ir

This week, Deutsche Numis held its annual Investment Companies Analyst Best Ideas Conference, which was a great opportunity to hear from the team, including Ewan Lovett-Turner, colette ord, Gavin Trodd, Andy Rees and Ash Nandi, who were keen to share their top picks and unique sector insights with an engaged investor audience. The team kicked off with an overview of the investment companies space, where we are seeing discounts at their widest levels since the post-Global Financial Crisis era. Over the past few years, there has been a material change in the level of discount, which is reflected in the fact that 85% of the universe is trading on a 5% or wider discount, leading issuance to dry up. They then considered the changing investment interest in this sector, with new buyers to the sector largely made up of: ✔ Companies – buybacks are at near record levels. ✔ Value players – some are taking meaningful stakes, signalling the potential available value in the space. ✔ Retail investors - there is some scope for strongly performing funds to attract this group. ✔ Strategic buyers – M&A has picked up, including take-privates. Finally, the team gave a deeper dive into the appeal of various asset classes for different portfolios, including equity investment companies, infrastructure, private equity and property, ultimately concluding that delivering on the return profiles is likely to be the key to attracting widespread buyers back into this sector. Read more here: https://lnkd.in/eydT45GM #InvestmentCompanies L-R: Ewan Lovett-Turner, Colette Ord, Ash Nandi

Die #KEPLER Investment-Philosophie bei Anleihen: #Anleihen managen wir aus einem anderen Blickwinkel. Weil wir dabei auch in Nischen-Segmenten Ertragspotenziale heben. #fonds #keplerfonds #investment #investieren #marketing #geldanlage

New private markets investment vehicles are creating fresh opportunities for RIAs to diversify and expand their portfolios. I discussed these opportunities and more with @RIA Channel . Thanks to Keith Black, PhD, CFA, CAIA, FDP, CDAA for speaking with me on the evolving landscape of private market investments designed for accredited investors and how these changes are shaping the industry. Watch the full interview: https://lnkd.in/eks2h_ik

Private Equity Investments sind eine attraktive Möglichkeit, in nicht börsennotierte Unternehmen zu investieren, und der Small-Cap-Sektor bietet besondere Chancen. Diversifizierte Private Equity Fund Portfolios im Small-Cap-Bereich haben mehrere Vorteile, die Investoren ansprechen sollten. Erfahren Sie mehr über die wichtigsten Vorteile dieser Fundklasse. #SMEAdvisors, #Growth, #SMEGrowth, #SMEGrowthFunds, #Privateequity, #PEfunds, #Privatedebt, #catgrowth, #pmeconsults, #growthfinancing, #KMUFinanzierung , #Wachstumsfinanzierung, #Nachfolgefinanzierung, #privatemarkets , #impactinvesting Martin Ziehbrunner Andreas Schimanski Peter Koller Christoph Krammer Beat Saurer Dominik Probst Dominik Habermacher Marc Z. Simon Frei Gabriela Loepfe-Lazar Mario Solenicki Jonas Greminger Raphael Ledergerber David Klee Andre Grethler Hans-Peter Kellenberger Mike Bürgler Mariana Ziehbrunner-Petrache

Booming Life Sciences Investments: Private Equity's Analytical Bias Discover why life sciences investments are flourishing and how private equity firms prioritize numbers for analysis. Explore the global trend of buyout funds and the continuous growth it brings. Find out why this field remains a promising avenue for investment. #LifeSciencesInvestments #PrivateEquity #GlobalTrend #BuyoutFunds #InvestmentOpportunity #FinancialAnalysis #PromisingField #GrowthPotential #AnalyticalBias #InvestmentStrategy Guy Paul Nohra

Im Small Cap Bereich sind die Firmenbewertungen wieder auf einem interessanten Niveau angekommen und bieten gute Möglichkeiten für einen Einstieg. Bei den SME Growth Funds können die im Paper beschriebenen Vorteile erreicht werden.

Embera Partners Capital Markets and IR weekly highlights: This weeks version of the D/A/CH weekly shines a light on some of the volatile markets, with several issuers moving double digit in a week which was affected by the triple witching days. Otherwise, interesting market development linked to geopolitical developments, election dates and worries on economic outlook. Last week’s top performers: Porsche AG (+15.0%) leading the @DAX ZEISS Group (+25.5%) leading the @MDAX Verbio SE (+24.5%) leading the @SDAX Richemont (+17.5%) on top of the SMI Lenzing Group (+11.1%) on top of the @ATXPrime Last week’s laggards: Rheinmetall (-1.1%), main detractor in the @DAX Aurubis (-6.8%), main detractor in the in the @MDAX Mutares SE & Co. KGaA (-24.1%), main detractor in the in the @SDAX Novartis (-1.1%), main detractor in the @SMI IMMOFINANZ (-21.7%), main detractor in the @ATXPrime On the options and derivative side, the following companies were in the spotlight: 👉 Short Interest Alerts: Daimler Truck AG, WACKER, Douglas Group, Erste Group and GAM Holding AG 👉 On the options side, our monitor showed strong movements at Lindt & Sprüngli and CA Immobilien Anlagen AG (CA Immo) as well as IMMOFINANZ and Porsche AG. Some of the key news and most-discussed articles can be found below. All links to the relevant news can be accessed through the weekly: Franklin Templeton: Election Outlook  https://lnkd.in/d2_S3akq Gotham City Research : Short Attach on Mutares (Report) https://lnkd.in/dSa8ZUHP Boston Consulting Group (BCG): Carbon Emissions Survey https://lnkd.in/dKNqvxuc    Goldman Sachs and BlackRock: European stocks face hurdles https://lnkd.in/deQeUGMg   In order to receive the weekly every Sunday in your mailbox, please follow us at Embera Partners or sign up to the newsletter here: https://lnkd.in/dHmSjyGU The weekly includes IR-related highlights including a short re-cap of last weeks developments and an outlook of what should be relevant news for senior decision makers over the next couple of days. The weekly will include our own proprietary insights and intelligence, as well as external, curated, data and links to news with focus on buy-side, investor relations, sustainability and governance, M&A, IPO and activism, which we deem interesting as food-for-thought. #emberapartners,#capmarkets, #investorrelations, #esg, #governance, #ipo, #transactions, #mergers, #buyside, #sellside, #capitalaccess Andreas Posavac